Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences

Nucleic Acids Research

Volumn 31, Issue 19, 2003, Pages 5635-5643

  Xu, Qiang ^a   Lee, Christopher ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR RECEPTOR 1; LACTATE DEHYDROGENASE ISOENZYME; MESSENGER RNA; MYELIN BASIC PROTEIN; PROTEIN BCL 2; RIBOSOME PROTEIN; S6 KINASE; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; GENE FUNCTION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; PRIORITY JOURNAL; RNA SEQUENCE; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE; UPREGULATION; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; GENOME; METABOLISM; NEOPLASM; REPRODUCIBILITY; TISSUE DISTRIBUTION;

ALTERNATIVE SPLICING; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, NEOPLASM; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 0141974926     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg786     Document Type: Article

References (38)

1. Ross,D.T., Scherf,U., Eisen,M.B., Perou,C.M., Rees,C., Spellman,P., Iyer,V., Jeffrey,S.S., Van de Rijn,M., Waltham,M. et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nature Genet., 24, 227-235.
2. Mironov,A.A., Fickett,J.W. and Gelfand,M.S. (1999) Frequent alternative splicing of human genes. Genome Res., 9, 1288-1293.
3. Brett,D., Hanke,J., Lehmann,G., Haase,S., Delbruck,S., Krueger,S., Reich,J. and Bork,P. (2000) EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett., 474, 83-86.
4. Croft,L., Schandorff,S., Clark,F., Burrage,K., Arctander,P. and Mattick,J.S. (2000) ISIS, the intron information system, reveals the high frequency of alternative splicing in the human genome. Nature Genet., 24, 340-341.
5. IHGS Consortium (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921.
6. Kan,Z., Rouchka,E.C., Gish,W.R. and States,D.J. (2001) Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res., 11, 889-900.
7. Modrek,B., Resch,A., Grasso,C. and Lee,C. (2001) Genome-wide analysis of alternative splicing using human expressed sequence data. Nucleic Acids Res., 29, 2850-2859.
8. Wikstrand,C.J., Hale,L.P., Batra,S.K., Hill,M.L., Humphrey,P.A., Kurpad,S.N., McLendon,R.E., Moscatello,D., Pegram,C.N., Reist,C.J. et al. (1995) Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res., 55, 3140-3148.
9. Naor,D., Nedvetzki,S., Golan,I., Melnik,L. and Faitelson,Y. (2002) CD44 in cancer. Crit. Rev. Clin. Lab. Sci., 39, 527-579.
10. Saito,H., Nakatsuru,S., Inazawa,J., Nishihira,T., Park,J.G. and Nakamura,Y. (1997) Frequent association of alternative splicing of NER, a nuclear hormone receptor gene in cancer tissues. Oncogene, 14, 617-621.
11. Parareda,A., Villaescusa,J.C., Sanchez de Toledo,J. and Gallego,S. (2003) New splicing variants for human Tyrosine Hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma. Neurosci. Lett., 336, 29-32.
12. Koslowski,M., Tureci,O., Bell,C., Krause,P., Lehr,H.A., Brunner,J., Seitz,G., Nestle,F.O., Huber,C. and Sahin,U. (2002) Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res., 62, 6750-6755.
13. Feltes,C.M., Kudo,A., Blaschuk,O. and Byers,S.W. (2002) An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res., 62, 6688-6697.
14. Castellani,P., Borsi,L., Camemolla,B., Biro,A., Dorcaratto,A., Viale,G.L., Neri,D. and Zardi,L. (2002) Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin. Am. J. Pathol., 161, 1695-1700.
15. Chiarugi,V., Del Rosso,M. and Magnelli,L. (2002) Bm-3a, a neuronal transcription factor of the POU gene family: indications for its involvement in cancer and angiogenesis. Mol. Biotechnol., 22, 123-127.
16. Wang,Z., Lo,H.S., Yang,H., Gere,S., Hu,Y., Buetow,K.H. and Lee,M.P. (2003) Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res., 63, 655-657.
17. Cragg,M.S., Chan,H.T., Fox,M.D., Tutt,A., Smith,A., Oscier,D.G., Hamblin,T.J. and Glennie,M.J. (2002) The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. Blood, 100, 3068-3076.
18. Ge,K., DuHadaway,J., Du,W., Herlyn,M., Rodeck,U. and Prendergast,G.C. (1999) Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc. Natl Acad. Sci. USA, 96, 9689-9694.
19. LeHir,H., Charlet-Berguerand,N., de Franciscis,V. and Thermes,C. (2002) 5′-End RET splicing: absence of variants in normal tissues and intron retention in pheochromocytomas. Oncology, 63, 84-91.
20. Lewis,B.P., Green,R.E. and Brenner,S.E. (2003) Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl Acad. Sci. USA, 100, 189-192.
21. Skandalis,A., Ninniss,P.J., McCormac,D. and Newton,L. (2002) Spontaneous frequency of exon skipping in the human HPRT gene. Mutat. Res., 501, 37-44.
22. Bartoszynski,R. and Niewiadomska-Bugaj,M. (1996) Probability and Statistical Inference. John Wiley & Sons, New York, NY, USA.
23. Kan,Z., States,D. and Gish,W. (2002) Selecting for functional alternative splices in ESTs. Genome Res., 12, 1837-1845.
24. Xu,Q., Modrek,B. and Lee,C. (2002) Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res., 30, 3754-3766.
25. Yang,C., Zhou,D. and Chen,S. (1998) Modulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptor. Cancer Res., 58, 5695-5700.
26. Lu,D., Kiriyama,Y., Lee,K.Y. and Giguere,V. (2001) Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Res., 61, 6755-6761.
27. Chen,S., Zhou,D., Yang,C. and Sherman,M. (2001) Molecular basis for the constitutive activity of estrogen-related receptor alpha-1. J. Biol. Chem., 276, 28465-28470.
28. Xie,W., Hong,H., Yang,N.N., Lin,R.J., Simon,C.M., Stallcup,M.R. and Evans,R.M. (1999) Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Mol. Endocrinol., 13, 2151-2162.
29. Hong,H., Yang,L. and Stallcup,M.R. (1999) Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J. Biol. Chem., 274, 22618-22626.
30. Greschik,H., Wurtz,J.M., Sanglier,S., Bourguet,W., van Dorsselaer,A., Moras,D. and Renaud,J.P. (2002) Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol. Cell, 9, 303-313.
31. Peethambaram,P.P., Ingle,J.N., Suman,V.J., Hartmann,L.C. and Loprinzi,C.L. (1999) Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Res. Treat., 54, 117-122.
32. Malkowicz,S.B. (2001) The role of diethylstilbestrol in the treatment of prostate cancer. Urology, 58, 108-113.
33. Reddel,R.R. and Sutherland,R.L. (1987) Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Cancer Res., 47, 5323-5329.
34. Xia,Y.F., Li,Y.D., Li,X. and Geng,J.G. (2002) Identification of alternatively spliced Act1 and implications for its roles in oncogenesis. Biochem. Biophys. Res. Commun., 296, 406-412.
35. Whitman,S., Wang,X., Shalaby,R. and Shtivelman,E. (2000) Alternatively spliced products CC3 and TC3 have opposing effects on apoptosis. Mol. Cell. Biol., 20, 583-593.
36. Yamaguchi,F., Saya,H., Bruner,J.M. and Morrison,R.S. (1994) Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl Acad. Sci. USA, 91, 484-488.
37. Jin,W., Huang,E.S., Bi,W. and Cote,G.J. (1999) Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells. J. Biol. Chem., 274, 28035-28041.
38. Correa,R.G., de Carvalho,A.F., Pinheiro,N.A., Simpson,A.J. and de Souza,S.J. (2000) NABC1 (BCAS1): alternative splicing and downregulation in colorectal tumors. Genomics, 65, 299-302.